Skip to main content
. 2017 Feb 8;4(2):e327. doi: 10.1212/NXI.0000000000000327

Figure 1. GALA study design.

Figure 1

*Only clinical visits involving complete neurologic and physical examination are represented in this figure. GA40 = glatiramer acetate 40 mg/mL 3-times-weekly SC injection; R = randomization.